NIH and CDC support critical research and education programs for individuals with blood disorders (WASHINGTON—September 10, 2025) – The American Society of Hematology (ASH) applauds the House and Senate Appropriations Committees for rejecting the Tr...

Substantial improvements seen across ages in overall health and wellbeing (WASHINGTON — August 27, 2025) – Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with se...

$150,000 grants serve as a one-year bridge for researchers threatened by federal budget cuts to the National Institutes of Health (NIH) (WASHINGTON, August 19, 2025) – In an effort to counteract federal research funding cuts, the American Socie...

Over half of eligible patients do not receive recommended therapies or complete the full course of treatment; white males are most likely to get the right treatment at the right dose (WASHINGTON – August 6, 2025) – Most patients with high...

Findings at odds with increasing use of the therapy in clinical practice (WASHINGTON, July 31, 2025) — In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced...

Significant cuts to Medicaid endanger millions of Americans, including those with hematologic disorders (WASHINGTON — July 3, 2025) – The United States Senate and House of Representatives both voted to pass H.R.1, also known as the “One Big Beautiful...

ASH recognizes 11 hematologists with top awards and distinguished lectures (WASHINGTON, June 18, 2025) — The American Society of Hematology (ASH) will recognize 11 hematologists who have made significant contributions to the field with several...

Despite the withdrawal of these implants, many women have them and should be aware of the related risk (WASHINGTON, June 13, 2025) – Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants...

The Society’s significant investment will expand awards funding as part of a larger multifaceted initiative to protect hematology research and the care of patients (WASHINGTON, June 10, 2025) – Amid threats to funding for hematology rese...

A nearly 40% reduction in funding would devastate essential progress in hematology research and unnecessarily endanger patients living with blood disorders (WASHINGTON—June 6, 2025) – Yesterday, the Administration published details of the...